COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Daniel Prieto‐Alhambra, Arani Vivekanantham et al.|Lara D. Veeken|2021Cited by 53
Unraveling COVID-19: A Large-Scale Characterization of 4.5 Million COVID-19 Cases Using CHARYBDISKristin Kostka, Nicole G. Weiskopf, Hong Zhu et al.|Clinical Epidemiology|2022Cited by 26
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021Nicola L. Barclay, Marek Oja, Sarah Collen et al.|Scientific Reports|2024Cited by 25
The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort AnalysisNicola L. Barclay, Danielle Newby, Ilona Tietzova et al.|Clinical Epidemiology|2024Cited by 18
Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database AnalysisXintong Li, Daniel Prieto‐Alhambra, Evan Minty et al.|Frontiers in Pharmacology|2021Cited by 13